Aytu Biopharma (AYTU) Change in Receivables (2015 - 2026)
Aytu Biopharma (AYTU) posted Change in Receivables of -$1.71 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$4.67 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Change in Receivables (2015 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Change in Receivables came in at -$8.38 million.
- In prior fiscal years, Aytu Biopharma's Change in Receivables was $7.63 million in FY2025, -$5.2 million in FY2024, $7.15 million in FY2023 and -$6.53 million in FY2022.
- Quarterly Change in Receivables has run from a low of -$6.53 million in fiscal Q1 2022 to a high of $10.51 million in fiscal Q3 2025 over five years.
- According to Business Quant data, Change in Receivables for the three prior fiscal quarters was -$6.43 million (Q3 2026), -$2.3 million (Q2 2026) and $2.07 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | -1.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71 Mn |
| Mar 31, 2026 | -6.43 Mn |
| Dec 31, 2025 | -2.30 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | -4.67 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | -478,000.00 |
| Jun 30, 2024 | -5.73 Mn |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | 621,000.00 |
| Sep 30, 2023 | 945,000.00 |
| Jun 30, 2023 | -5.18 Mn |
| Mar 31, 2023 | 8.50 Mn |
| Dec 31, 2022 | -2.38 Mn |
| Sep 30, 2022 | 6.21 Mn |
| Jun 30, 2022 | -5.89 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | -6.53 Mn |
API Access
Aytu Biopharma Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();